Konstantin Poukalov Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Konstantin Poukalov.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Konstantin Poukalov. Konstantin Poukalov is Director in Lyra Therapeutics, Inc. ($LYRA) and EVP, Chief Financial Officer in Kadmon Holdings, Inc. ($KDMN) and Executive Vice President, CFO in Kadmon Holdings, Inc. ($KDMN) and Director in Landos Biopharma, Inc. ($LABP).
Latest Insider Trading Transactions of Konstantin Poukalov
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, KDMN, LABP, LYRA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 14.60 | 34,951 | 510,285 | 14,869,915 | 14.8 M to 14.9 M (+0.24 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 13.80 | 64,730 | 893,274 | 14,834,964 | 14.8 M to 14.8 M (+0.44 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 13.10 | 1,771 | 23,200 | 14,770,234 | 14.8 M to 14.8 M (+0.01 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 12.53 | 86,671 | 1,085,988 | 14,768,463 | 14.7 M to 14.8 M (+0.59 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 11.38 | 34,611 | 393,873 | 14,681,792 | 14.6 M to 14.7 M (+0.24 %) |
| Feb 09 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 11.14 | 27,453 | 305,826 | 14,647,181 | 14.6 M to 14.6 M (+0.19 %) |
| Feb 08 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Option Exercise | C | 0.00 | 7,486,190 | 0 | 0 | |
| Feb 08 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Option Exercise | C | 0.00 | 5,883,538 | 0 | 0 | |
| Feb 08 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | P | 16.00 | 1,250,000 | 20,000,000 | 14,619,728 | 13.4 M to 14.6 M (+9.35 %) |
| Feb 08 2021 | LABP | Landos Biopharma, ... | Poukalov Konstantin | Director | Buy | C | 0.00 | 13,369,728 | 0 | 13,369,728 | 0 to 13.4 M |
| May 01 2020 | LYRA | Lyra Therapeutics, ... | Poukalov Konstantin | Director | Option Exercise | A | 16.00 | 14,500 | 232,000 | 14,500 | |
| Dec 12 2017 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | Executive Vice Pres ... | Option Exercise | A | 3.64 | 205,000 | 746,200 | 205,000 | |
| Dec 16 2016 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | Executive Vice Pres ... | Option Exercise | A | 4.66 | 350,000 | 1,631,000 | 350,000 | |
| Nov 14 2016 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | EVP, Chief Financia ... | Buy | P | 5.43 | 1,000 | 5,430 | 4,000 | 3 K to 4 K (+33.33 %) |
| Nov 14 2016 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | EVP, Chief Financia ... | Buy | P | 5.95 | 1,000 | 5,950 | 3,000 | 2 K to 3 K (+50.00 %) |
| Nov 14 2016 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | EVP, Chief Financia ... | Buy | P | 5.91 | 1,000 | 5,910 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Nov 14 2016 | KDMN | Kadmon Holdings, I ... | Poukalov Konstantin | EVP, Chief Financia ... | Buy | P | 5.96 | 1,000 | 5,960 | 1,000 | 0 to 1,000 |
Page: 1